Clinical relevance of CD44 cell surface expression and MYCN gene amplification in neuroblastoma

By Combaret V.   Gross N.   Lasset C.   Frappaz D.   Beretta-Brognara C.   Philip T.   Beck D.   Favrot M.C.  

European Journal of Cancer, Vol. 33, Iss. 12, 1997-10 ,pp. : 2101-2105

Elsevier

Access to resources Recommend Favorite

Relationship of DDX1 and NAG gene amplification/overexpression to the prognosis of patients with MYCN-amplified neuroblastoma

By Kaneko Setsuko   Ohira Miki   Nakamura Yohko   Isogai Eriko   Nakagawara Akira   Kaneko Michio  

Journal of Cancer Research and Clinical Oncology, Vol. 133, Iss. 3, 2007-03 ,pp. : 185-192

Springer Publishing Company

Access to resources Recommend Favorite

Evidence that the MYCN oncogene regulates MRP gene expression in neuroblastoma

By Norris M.D.   Bordow S.B.   Haber P.S.   Marshall G.M.   Kavallaris M.   Madafiglio J.   Cohn S.L.   Salwen H.   Schmidt M.L.   Hipfner D.R.   Cole S.P.C.   Deeley R.G.   Haber M.  

European Journal of Cancer, Vol. 33, Iss. 12, 1997-10 ,pp. : 1911-1916

Elsevier

Access to resources Recommend Favorite

Microarray data analysis of neuroblastoma: Expression of SOX2 downregulates the expression of MYCN

By              

Molecular Medicine Reports, Vol. 12, Iss. 5, 2015-01 ,pp. : 6867-6872

Spandidos Publications

Access to resources Recommend Favorite

Correlation of MYCN amplification, Trk-A and CD44 expression with clinical stage in 250 patients with neuroblastoma

By Kramer K.   Cheung N.-K.V.   Gerald W.L.   LaQuaglia M.   Kushner B.H.   LeClerc J.-M.   LeSauter L.   Saragovi H.U.  

European Journal of Cancer, Vol. 33, Iss. 12, 1997-10 ,pp. : 2098-2100

Elsevier

Access to resources Recommend Favorite